Park Eun Jeong, Ji Hye Young, Kim Nam Jin, Song Won Young, Kim Young Hoon, Kim Youn-Chul, Sohn Dong Hwan, Lee Hye Suk
College of Pharmacy, Wonkwang University, Iksan 570-749, Korea.
Biomed Chromatogr. 2008 May;22(5):548-55. doi: 10.1002/bmc.968.
A rapid, sensitive and selective liquid chromatography-tandem mass spectrometric (LC-MS/MS) method for the simultaneous determination of tanshinone I, dihydrotanshinone I, tanshinone IIA and cryptotanshinone, the active components of Salvia miltiorrhiza in rat plasma, was developed. After liquid-liquid extraction with tariquidar as an internal standard, tanshinone I, dihydrotanshinone I, tanshinone IIA and cryptotanshinone were eluted from an Atlantis dC18 column within 5 min with a mixture of methanol and ammonium formate (10 mm, pH 6.5; 85:15, v/v). The analytes were detected by an electrospray ionization tandem mass spectrometry in the selected reaction monitoring (SRM) mode. The standard curves were linear (r=0.999) over the concentration range of 0.25-80 ng/mL for tanshinone I, dihydrotanshinone I, tanshinone IIA and cryptotanshinone in rat plasma. The coefficients of variation and the relative errors of tanshinone I, dihydrotanshinone I, tanshinone IIA and cryptotanshinone for intra- and inter-assay at four quality control (QC) concentrations were 1.1-5.1% and -4.0-6.0%, respectively. The lower limit of quantification for tanshinone I, dihydrotanshinone I, tanshinone IIA and cryptotanshinone was 0.25 ng/mL from 100 microL of plasma. This method was successfully applied to the pharmacokinetic study of tanshinone I, dihydrotanshinone I, tanshinone IIA and cryptotanshinone after oral administration of PF2401-SF, the standardized fraction of Salvia miltiorrhiza enriched with tanshinone I, dihydrotanshinone I, tanshinone IIA and cryptotanshinone to male Sprague-Dawley rats.
建立了一种快速、灵敏且选择性好的液相色谱-串联质谱(LC-MS/MS)方法,用于同时测定丹参活性成分丹参酮Ⅰ、二氢丹参酮Ⅰ、丹参酮ⅡA和隐丹参酮在大鼠血浆中的含量。以 tariquidar 为内标进行液-液萃取后,丹参酮Ⅰ、二氢丹参酮Ⅰ、丹参酮ⅡA和隐丹参酮在 Atlantis dC18 柱上于 5 分钟内被甲醇和甲酸铵(10 mM,pH 6.5;85:15,v/v)混合液洗脱。通过电喷雾电离串联质谱在选择反应监测(SRM)模式下检测分析物。丹参酮Ⅰ、二氢丹参酮Ⅰ、丹参酮ⅡA和隐丹参酮在大鼠血浆中的浓度范围为 0.25 - 80 ng/mL 时,标准曲线呈线性(r = 0.999)。在四个质量控制(QC)浓度下,丹参酮Ⅰ、二氢丹参酮Ⅰ、丹参酮ⅡA和隐丹参酮的批内和批间变异系数及相对误差分别为 1.1 - 5.1%和 -4.0 - 6.0%。丹参酮Ⅰ、二氢丹参酮Ⅰ、丹参酮ⅡA和隐丹参酮的定量下限为 100 μL 血浆中的 0.25 ng/mL。该方法成功应用于雄性 Sprague-Dawley 大鼠口服富含丹参酮Ⅰ、二氢丹参酮Ⅰ、丹参酮ⅡA和隐丹参酮的丹参标准化提取物 PF2401-SF 后,丹参酮Ⅰ、二氢丹参酮Ⅰ、丹参酮ⅡA和隐丹参酮的药代动力学研究。